Elite Pharmaceuticals, Inc. (ELI) Announces FDA Approval of Supplemental Application for Hydromorphone
1/26/2012 9:05:58 AM
NORTHVALE, N.J., Jan. 26, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that on January 23, 2012, the U.S. Food and Drug Administration approved the Company's supplemental application for the manufacturing and packaging of Hydromorphone Hydrochloride USP 8 mg. This approval will allow the Company to commence the commercial manufacturing and packaging of this product for its sales and marketing partner, which will distribute the product as part of a multi-product distribution agreement.
comments powered by